{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:58:41Z","timestamp":1788559121017,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":833,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pathology Informatics"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.4103\/jpi.jpi_52_19","type":"journal-article","created":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T04:28:07Z","timestamp":1580790487000},"page":"2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["A Validation Study of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Digital Imaging Analysis and its Correlation with Human Epidermal Growth Factor Receptor 2 Fluorescence In situ Hybridization Results in Breast Carcinoma"],"prefix":"10.1016","volume":"11","author":[{"given":"Ramon","family":"Hartage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan C.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil V.","family":"Parwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4103\/jpi.jpi_52_19_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: Correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"10.4103\/jpi.jpi_52_19_bib2","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1200\/JCO.1989.7.8.1120","article-title":"HER-2\/neu oncogene protein and prognosis in breast cancer","volume":"7","author":"Tandon","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.4103\/jpi.jpi_52_19_bib3","first-page":"4960","article-title":"Her-2\/neu expression in node-negative breast cancer: Direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease","volume":"53","author":"Press","year":"1993","journal-title":"Cancer Res"},{"key":"10.4103\/jpi.jpi_52_19_bib4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3816\/CBC.2008.n.047","article-title":"Unraveling the biologic and clinical complexities of HER2","volume":"8","author":"Park","year":"2008","journal-title":"Clin Breast Cancer"},{"key":"10.4103\/jpi.jpi_52_19_bib5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.4103\/jpi.jpi_52_19_bib6","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","article-title":"Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer","volume":"353","author":"Romond","year":"2005","journal-title":"N Engl J Med"},{"key":"10.4103\/jpi.jpi_52_19_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1113216","article-title":"Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N Engl J Med"},{"key":"10.4103\/jpi.jpi_52_19_bib8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1200\/JCO.2002.20.3.719","article-title":"Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer","volume":"20","author":"Vogel","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.4103\/jpi.jpi_52_19_bib9","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline focused update","volume":"36","author":"Wolff","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.4103\/jpi.jpi_52_19_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1016146130767","article-title":"Evaluation of HER-2\/NEU protein expression in breast cancer by immunohistochemistry: An interlaboratory study assessing the reproducibility of HER-2\/NEU testing","volume":"74","author":"Gancberg","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.4103\/jpi.jpi_52_19_bib11","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.1999.17.7.1974","article-title":"Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2\/neu in breast cancer","volume":"17","author":"Jacobs","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.4103\/jpi.jpi_52_19_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10549-011-1514-2","article-title":"Digital image analysis of membrane connectivity is a robust measure of HER2 immunostains","volume":"132","author":"Br\u00fcgmann","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.4103\/jpi.jpi_52_19_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2559.2010.03577.x","article-title":"Image analysis as an adjunct to manual HER-2 immunohistochemical review: A diagnostic tool to standardize interpretation","volume":"57","author":"Dobson","year":"2010","journal-title":"Histopathology"},{"key":"10.4103\/jpi.jpi_52_19_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00428-015-1868-7","article-title":"Free digital image analysis software helps to resolve equivocal scores in HER2 immunohistochemistry","volume":"468","author":"Helin","year":"2016","journal-title":"Virchows Arch"},{"key":"10.4103\/jpi.jpi_52_19_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1746-1596-6-87","article-title":"Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: Algorithm evaluation on breast cancer tissue microarrays","volume":"6","author":"Laurinaviciene","year":"2011","journal-title":"Diagn Pathol"},{"key":"10.4103\/jpi.jpi_52_19_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jcp.2007.046763","article-title":"Comparing subjective and digital image analysis HER2\/neu expression scores with conventional and modified FISH scores in breast cancer","volume":"61","author":"Skaland","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.4103\/jpi.jpi_52_19_bib17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10549-015-3475-3","article-title":"Optimizing HER2 assessment in breast cancer: Application of automated image analysis","volume":"152","author":"Holten-Rossing","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.4103\/jpi.jpi_52_19_bib18","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.5858\/arpa.2018-0378-CP","article-title":"Quantitative image analysis of human epidermal growth factor receptor 2 immunohistochemistry for breast cancer: Guideline from the college of American pathologists","volume":"143","author":"Bui","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"10.4103\/jpi.jpi_52_19_bib19","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/his.13812","article-title":"What is the added value of digital image analysis of HER2 immunohistochemistry in breast cancer in clinical practice? A study with multiple platforms","volume":"74","author":"Koopman","year":"2019","journal-title":"Histopathology"},{"key":"10.4103\/jpi.jpi_52_19_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/his.13322","article-title":"Digital image analysis of HER2 immunohistochemistry in gastric- and oesophageal adenocarcinoma: A validation study on biopsies and surgical specimens","volume":"72","author":"Koopman","year":"2018","journal-title":"Histopathology"},{"key":"10.4103\/jpi.jpi_52_19_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121945","article-title":"Cocor: A comprehensive solution for the statistical comparison of correlations","volume":"10","author":"Diedenhofen","year":"2015","journal-title":"PLoS One"},{"key":"10.4103\/jpi.jpi_52_19_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/bjc.2011.569","article-title":"Comparison of visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer","volume":"106","author":"Mohammed","year":"2012","journal-title":"Br J Cancer"},{"key":"10.4103\/jpi.jpi_52_19_bib23","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2559.2011.04142.x","article-title":"ImmunoMembrane: A publicly available web application for digital image analysis of HER2 immunohistochemistry","volume":"60","author":"Tuominen","year":"2012","journal-title":"Histopathology"},{"key":"10.4103\/jpi.jpi_52_19_bib24","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1200\/JCO.2008.19.7939","article-title":"Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: The HERA trial","volume":"27","author":"Dowsett","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.4103\/jpi.jpi_52_19_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.humpath.2018.08.005","article-title":"Breast cancers with a HER2\/CEP17 ratio of 2.0 or greater and an average HER2 copy number of less than 4.0 per cell: Frequency, immunohistochemical correlation, and clinicopathological features","volume":"83","author":"Zare","year":"2019","journal-title":"Hum Pathol"},{"key":"10.4103\/jpi.jpi_52_19_bib26","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2013.53.9213","article-title":"Interpretation of human epidermal growth factor receptor 2 (HER2) in situ hybridization assays using 2013 update of American Society of Clinical Oncology\/College of American Pathologists HER2 guidelines","volume":"32","author":"Bhargava","year":"2014","journal-title":"J Clin Oncol"}],"container-title":["Journal of Pathology Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2153353922002310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2153353922002310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:45:15Z","timestamp":1761871515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2153353922002310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S2153353922002310"],"URL":"https:\/\/doi.org\/10.4103\/jpi.jpi_52_19","relation":{},"ISSN":["2153-3539"],"issn-type":[{"value":"2153-3539","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Validation Study of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Digital Imaging Analysis and its Correlation with Human Epidermal Growth Factor Receptor 2 Fluorescence In situ Hybridization Results in Breast Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Pathology Informatics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4103\/jpi.jpi_52_19","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 THE AUTHORS. Published by Elsevier Inc on behalf of the Association for Pathology Informatics","name":"copyright","label":"Copyright"}],"article-number":"2"}}